Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Optical Coherence | 14 | 2024 | 236 | 2.700 |
Why?
|
| Intracranial Aneurysm | 12 | 2024 | 382 | 2.660 |
Why?
|
| Stents | 8 | 2024 | 501 | 1.580 |
Why?
|
| Disease Models, Animal | 11 | 2026 | 2327 | 1.500 |
Why?
|
| Catheters | 6 | 2024 | 83 | 1.190 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2024 | 98 | 1.180 |
Why?
|
| Self Expandable Metallic Stents | 5 | 2020 | 33 | 1.080 |
Why?
|
| Rabbits | 10 | 2024 | 342 | 1.030 |
Why?
|
| Thrombosis | 5 | 2020 | 207 | 1.010 |
Why?
|
| Phosphorylcholine | 2 | 2024 | 45 | 0.940 |
Why?
|
| Hypothermia, Induced | 2 | 2024 | 48 | 0.850 |
Why?
|
| Endovascular Procedures | 8 | 2024 | 631 | 0.850 |
Why?
|
| Embolization, Therapeutic | 6 | 2020 | 337 | 0.810 |
Why?
|
| Heparin | 1 | 2024 | 120 | 0.770 |
Why?
|
| Peroxidase | 1 | 2023 | 70 | 0.770 |
Why?
|
| Dogs | 10 | 2024 | 326 | 0.770 |
Why?
|
| Animals | 31 | 2026 | 21467 | 0.700 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 23 | 0.650 |
Why?
|
| Aneurysm | 1 | 2020 | 58 | 0.620 |
Why?
|
| Aspirin | 2 | 2020 | 172 | 0.610 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 179 | 0.600 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2024 | 2262 | 0.560 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 235 | 0.550 |
Why?
|
| Stroke | 7 | 2023 | 1221 | 0.550 |
Why?
|
| Brain Ischemia | 4 | 2022 | 420 | 0.480 |
Why?
|
| Thrombectomy | 7 | 2023 | 263 | 0.420 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2023 | 70 | 0.370 |
Why?
|
| Basilar Artery | 2 | 2024 | 34 | 0.360 |
Why?
|
| Cerebral Angiography | 4 | 2023 | 303 | 0.360 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2024 | 140 | 0.360 |
Why?
|
| Cerebral Arteries | 2 | 2024 | 41 | 0.360 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2024 | 154 | 0.350 |
Why?
|
| Models, Anatomic | 3 | 2023 | 63 | 0.340 |
Why?
|
| Treatment Outcome | 11 | 2024 | 5820 | 0.320 |
Why?
|
| Phantoms, Imaging | 2 | 2024 | 239 | 0.310 |
Why?
|
| Neointima | 2 | 2018 | 21 | 0.280 |
Why?
|
| Genetic Therapy | 3 | 2026 | 852 | 0.270 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2018 | 215 | 0.250 |
Why?
|
| Genetic Vectors | 2 | 2026 | 929 | 0.250 |
Why?
|
| Cockayne Syndrome | 1 | 2026 | 5 | 0.240 |
Why?
|
| Dependovirus | 2 | 2026 | 760 | 0.240 |
Why?
|
| Swine | 3 | 2024 | 397 | 0.230 |
Why?
|
| Surface Properties | 2 | 2024 | 283 | 0.220 |
Why?
|
| Random Allocation | 3 | 2020 | 200 | 0.220 |
Why?
|
| Inflammation | 2 | 2023 | 1195 | 0.220 |
Why?
|
| Male | 11 | 2026 | 31298 | 0.220 |
Why?
|
| Middle Cerebral Artery | 2 | 2023 | 51 | 0.220 |
Why?
|
| Contrast Media | 2 | 2024 | 432 | 0.210 |
Why?
|
| Carotid Artery, Common | 1 | 2024 | 30 | 0.210 |
Why?
|
| Central Nervous System | 3 | 2024 | 200 | 0.210 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 990 | 0.200 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2023 | 6 | 0.200 |
Why?
|
| Microscopy | 2 | 2024 | 99 | 0.200 |
Why?
|
| Thromboembolism | 1 | 2024 | 74 | 0.200 |
Why?
|
| Drug-Eluting Stents | 1 | 2024 | 68 | 0.200 |
Why?
|
| Organometallic Compounds | 1 | 2023 | 71 | 0.190 |
Why?
|
| Wound Healing | 1 | 2024 | 193 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2023 | 300 | 0.190 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 328 | 0.180 |
Why?
|
| Iron | 1 | 2023 | 155 | 0.180 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 105 | 0.180 |
Why?
|
| Subarachnoid Space | 1 | 2022 | 15 | 0.180 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 45 | 0.170 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 41 | 0.170 |
Why?
|
| Embolism | 1 | 2021 | 41 | 0.170 |
Why?
|
| C9orf72 Protein | 1 | 2021 | 115 | 0.160 |
Why?
|
| Phenotype | 1 | 2024 | 1235 | 0.160 |
Why?
|
| Vertebral Artery | 1 | 2020 | 29 | 0.160 |
Why?
|
| Carotid Arteries | 1 | 2020 | 64 | 0.160 |
Why?
|
| Brain | 3 | 2024 | 1625 | 0.160 |
Why?
|
| Device Removal | 1 | 2020 | 64 | 0.150 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 45 | 0.150 |
Why?
|
| Cisterna Magna | 1 | 2019 | 17 | 0.150 |
Why?
|
| Cryotherapy | 1 | 2019 | 16 | 0.150 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 39 | 0.150 |
Why?
|
| Biomechanical Phenomena | 1 | 2020 | 295 | 0.140 |
Why?
|
| Hemodynamics | 1 | 2020 | 252 | 0.140 |
Why?
|
| Mutation | 3 | 2022 | 2672 | 0.140 |
Why?
|
| Neuronavigation | 1 | 2018 | 13 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 704 | 0.140 |
Why?
|
| Huntingtin Protein | 1 | 2019 | 151 | 0.140 |
Why?
|
| Acute Disease | 1 | 2020 | 663 | 0.140 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2017 | 73 | 0.140 |
Why?
|
| Forecasting | 1 | 2019 | 231 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 644 | 0.140 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 242 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 710 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 325 | 0.130 |
Why?
|
| Humans | 20 | 2026 | 65655 | 0.130 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 27 | 0.120 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2017 | 50 | 0.120 |
Why?
|
| Gene Expression | 1 | 2019 | 855 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2015 | 63 | 0.110 |
Why?
|
| Female | 7 | 2020 | 34311 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1634 | 0.090 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 277 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2023 | 6948 | 0.090 |
Why?
|
| Carotid Artery, Internal | 2 | 2023 | 69 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 872 | 0.080 |
Why?
|
| Sheep | 2 | 2021 | 194 | 0.080 |
Why?
|
| Time Factors | 1 | 2017 | 3777 | 0.080 |
Why?
|
| Mice | 4 | 2026 | 11174 | 0.070 |
Why?
|
| Pancreatic Elastase | 2 | 2020 | 32 | 0.070 |
Why?
|
| Hyperplasia | 2 | 2018 | 92 | 0.070 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2019 | 56 | 0.060 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2026 | 4 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 2 | 2020 | 184 | 0.060 |
Why?
|
| Ethiodized Oil | 1 | 2024 | 7 | 0.050 |
Why?
|
| Enbucrilate | 1 | 2024 | 9 | 0.050 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2024 | 10 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 1662 | 0.050 |
Why?
|
| Miniaturization | 1 | 2024 | 10 | 0.050 |
Why?
|
| Philadelphia Chromosome | 1 | 2023 | 4 | 0.050 |
Why?
|
| Imatinib Mesylate | 1 | 2023 | 34 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2023 | 35 | 0.050 |
Why?
|
| Intravital Microscopy | 1 | 2022 | 13 | 0.040 |
Why?
|
| Infarction | 1 | 2022 | 20 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 198 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 22 | 0.040 |
Why?
|
| Motor Activity | 1 | 2024 | 346 | 0.040 |
Why?
|
| Microsurgery | 1 | 2022 | 55 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 143 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2026 | 2168 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 316 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 321 | 0.040 |
Why?
|
| Arteries | 1 | 2020 | 81 | 0.040 |
Why?
|
| Angiography | 1 | 2020 | 154 | 0.040 |
Why?
|
| Cadaver | 1 | 2020 | 135 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 78 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 44 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 126 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2021 | 423 | 0.040 |
Why?
|
| Lung | 1 | 2024 | 969 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 222 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 372 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2019 | 30 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 140 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 257 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 242 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 183 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 207 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 166 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 427 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1291 | 0.030 |
Why?
|
| Cattle | 1 | 2019 | 320 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 83 | 0.030 |
Why?
|
| Catheterization | 1 | 2018 | 112 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 16 | 0.030 |
Why?
|
| Choline | 1 | 2017 | 23 | 0.030 |
Why?
|
| Angioplasty | 1 | 2017 | 53 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2018 | 125 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 809 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 935 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1227 | 0.030 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2018 | 226 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 240 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1581 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2496 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1715 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2011 | 63 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 491 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1052 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5466 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 18440 | 0.010 |
Why?
|